Miramar Capital, LLC Merck & Co., Inc. Transaction History

Miramar Capital, LLC

  • $437 Million
  • Q3 2025

A detailed history of Miramar Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Miramar Capital, LLC holds 106,201 shares of MRK stock, worth $9.86 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
106,201
Previous 86,516 22.75%
Holding current value
$9.86 Million
Previous $6.85 Million 30.15%
% of portfolio
2.04%
Previous 1.67%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$77.6 - $87.37 $1.53 Million - $1.72 Million
19,685 Added 22.75%
106,201 $8.91 Million
Q2 2025

Aug 13, 2025
BUY
$73.47 - $87.12 $75,600 - $89,646
1,029 Added 1.2%
86,516 $6.85 Million
Q1 2025

May 13, 2025
SELL
$83.01 - $101.02 $182,954 - $222,648
-2,204 Reduced 2.51%
85,487 $7.67 Million
Q4 2024

Feb 07, 2025
BUY
$96.31 - $114.76 $994,882 - $1.19 Million
10,330 Added 13.35%
87,691 $8.72 Million
Q3 2024

Nov 06, 2024
SELL
$111.15 - $128.97 $103,591 - $120,200
-932 Reduced 1.19%
77,361 $8.79 Million
Q2 2024

Aug 12, 2024
BUY
$123.8 - $132.96 $104,487 - $112,218
844 Added 1.09%
78,293 $9.69 Million
Q1 2024

May 08, 2024
SELL
$113.24 - $131.95 $159,668 - $186,049
-1,410 Reduced 1.79%
77,449 $10.2 Million
Q4 2023

Feb 09, 2024
SELL
$100.18 - $109.02 $287,416 - $312,778
-2,869 Reduced 3.51%
78,859 $8.6 Million
Q3 2023

Nov 07, 2023
SELL
$102.95 - $114.33 $320,071 - $355,451
-3,109 Reduced 3.66%
81,728 $8.41 Million
Q2 2023

Aug 11, 2023
SELL
$108.61 - $118.38 $115,886 - $126,311
-1,067 Reduced 1.24%
84,837 $9.79 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $2.77 Million - $3.09 Million
-26,940 Reduced 23.87%
85,904 $9.14 Million
Q4 2022

Feb 09, 2023
BUY
$87.44 - $112.11 $15,039 - $19,282
172 Added 0.15%
112,844 $12.5 Million
Q3 2022

Nov 10, 2022
SELL
$84.53 - $94.96 $1.75 Million - $1.96 Million
-20,690 Reduced 15.51%
112,672 $11.4 Million
Q2 2022

Aug 03, 2022
BUY
$83.49 - $94.64 $761,846 - $863,590
9,125 Added 7.34%
133,362 $12.2 Million
Q1 2022

May 10, 2022
BUY
$73.51 - $82.4 $1.07 Million - $1.2 Million
14,549 Added 13.26%
124,237 $10.2 Million
Q4 2021

Feb 08, 2022
BUY
$72.28 - $90.54 $757,494 - $948,859
10,480 Added 10.56%
109,688 $8.41 Million
Q3 2021

Nov 12, 2021
BUY
$71.68 - $78.83 $418,969 - $460,761
5,845 Added 6.26%
99,208 $7.45 Million
Q2 2021

Aug 06, 2021
BUY
$70.31 - $77.77 $117,628 - $130,109
1,673 Added 1.82%
93,363 $7.06 Million
Q1 2021

Apr 27, 2021
BUY
$68.86 - $81.11 $862,884 - $1.02 Million
12,531 Added 15.83%
91,690 $7.07 Million
Q4 2020

Feb 09, 2021
BUY
$71.77 - $79.65 $1.4 Million - $1.55 Million
19,475 Added 32.63%
79,159 $5.94 Million
Q3 2020

Oct 13, 2020
SELL
$73.18 - $82.95 $11,562 - $13,106
-158 Reduced 0.26%
59,684 $4.8 Million
Q2 2020

Aug 05, 2020
BUY
$70.42 - $80.13 $236,399 - $268,996
3,357 Added 5.94%
59,842 $4.89 Million
Q1 2020

May 06, 2020
SELL
$63.36 - $87.82 $88,450 - $122,596
-1,396 Reduced 2.41%
56,485 $4.35 Million
Q4 2019

Feb 05, 2020
SELL
$77.58 - $87.54 $28,394 - $32,039
-366 Reduced 0.63%
57,881 $5.11 Million
Q3 2019

Oct 22, 2019
BUY
$76.08 - $82.93 $541,080 - $589,798
7,112 Added 13.91%
58,247 $4.92 Million
Q2 2019

Aug 08, 2019
BUY
$69.84 - $81.59 $47,770 - $55,807
684 Added 1.36%
51,135 $4.18 Million
Q1 2019

May 13, 2019
SELL
$69.58 - $79.36 $82,104 - $93,644
-1,180 Reduced 2.29%
50,451 $4.2 Million
Q4 2018

Feb 14, 2019
BUY
$65.24 - $75.71 $3.37 Million - $3.91 Million
51,631 New
51,631 $4.05 Million

Others Institutions Holding MRK

# of Institutions
3,875
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Miramar Capital, LLC Portfolio

Follow Miramar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email